U&I Corporation (056090) - Total Assets
Based on the latest financial reports, U&I Corporation (056090) holds total assets worth ₩126.07 Billion KRW (≈ $85.44 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see U&I Corporation (056090) cash flow conversion for how efficiently the company converts equity into cash flow.
U&I Corporation - Total Assets Trend (2015–2025)
This chart illustrates how U&I Corporation's total assets have evolved over time, based on quarterly financial data. See today's stock price for U&I Corporation for real-time trading data and today's change.
U&I Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
U&I Corporation's total assets of ₩126.07 Billion consist of 30.5% current assets and 69.5% non-current assets. Explore 056090 net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 9.1% |
| Accounts Receivable | ₩7.25 Billion | 6.3% |
| Inventory | ₩15.39 Billion | 13.4% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩4.33 Billion | 3.8% |
| Goodwill | ₩6.65 Billion | 5.8% |
Asset Composition Trend (2015–2025)
This chart illustrates how U&I Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: U&I Corporation's current assets represent 30.5% of total assets in 2025, a decrease from 78.6% in 2015.
- Cash Position: Cash and equivalents constituted 9.1% of total assets in 2025, down from 16.8% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 13.4% of total assets.
U&I Corporation Competitors by Total Assets
Key competitors of U&I Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.81 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
|
Brainsway Ltd
NASDAQ:BWAY
|
USA | $121.97 Million |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$21.12 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
U&I Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.55 | 4.69 | 1.12 |
| Quick Ratio | 1.57 | 3.58 | 0.66 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩25.37 Billion | ₩41.48 Billion | ₩2.69 Billion |
U&I Corporation - Advanced Valuation Insights
This section examines the relationship between U&I Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.14 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 7.2% |
| Total Assets | ₩114.92 Billion |
| Market Capitalization | $419.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values U&I Corporation's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: U&I Corporation's assets grew by 7.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for U&I Corporation (2015–2025)
The table below shows the annual total assets of U&I Corporation from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩114.92 Billion ≈ $77.88 Million |
+7.20% |
| 2024-12-31 | ₩107.20 Billion ≈ $72.65 Million |
+35.53% |
| 2023-12-31 | ₩79.10 Billion ≈ $53.60 Million |
-44.08% |
| 2022-12-31 | ₩141.44 Billion ≈ $95.85 Million |
+88.43% |
| 2021-12-31 | ₩75.06 Billion ≈ $50.87 Million |
+16.50% |
| 2020-12-31 | ₩64.43 Billion ≈ $43.66 Million |
-9.35% |
| 2019-12-31 | ₩71.08 Billion ≈ $48.17 Million |
-5.05% |
| 2018-12-31 | ₩74.86 Billion ≈ $50.73 Million |
-5.33% |
| 2017-12-31 | ₩79.08 Billion ≈ $53.59 Million |
+19.52% |
| 2016-12-31 | ₩66.16 Billion ≈ $44.84 Million |
-14.55% |
| 2015-12-31 | ₩77.42 Billion ≈ $52.47 Million |
-- |
About U&I Corporation
CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cerv… Read more